
    
      This is a multicenter, double-blind, randomized, parallel-group, vehicle-controlled study to
      assess the safety and efficacy of dapsone 7.5% gel versus vehicle administered topically once
      daily for 12 weeks in patients with acne vulgaris.
    
  